Sohn TS, Han KA, Kim Y, Lee BW, et al. A 52-week efficacy and safety study of enavogliflozin versus dapagliflozin as an add-on to metformin in patients with type 2 diabetes mellitus: ENHANCE-M extension study. Diabetes Obes Metab 2024 Mar 8. doi: 10.1111/dom.15537.
PMID: 38456558